(Q71626706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

1 reference

1 reference

R F Holcombe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R M Stewart

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

K W Betzing

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

K Kannan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 June 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

394-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01517209

20 October 2019

exact match

0 references

cites work

Levamisole meets sulfhydryl requirements of CTLL-2 cells and mediates enhanced proliferative response to mitogen stimulation without increasing interleukin-2 production.

1 reference

12 December 2020

Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases

1 reference

12 December 2020

The multi-subunit interleukin-2 receptor

1 reference

12 December 2020

Levamisole circumvents inhibition of lymphocyte activation imposed by uremic serum.

1 reference

12 December 2020

Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study

1 reference

12 December 2020

Restoration of immune response by levamisole in B-77 virus induced tumor-bearing rats

1 reference

12 December 2020

Drug-Induced Restoration of Cutaneous Delayed Hypersensitivity in Anergic Patients with Cancer

1 reference

12 December 2020

Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer

1 reference

12 December 2020

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

12 December 2020

MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition

1 reference

12 December 2020

NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer

1 reference

12 December 2020

Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors

1 reference

12 December 2020

Natural killer cells: definition of a cell type rather than a function

1 reference

12 December 2020

1 reference

12 December 2020

Biology of natural killer cells

1 reference

12 December 2020

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

1 reference

12 December 2020

MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness

1 reference

12 December 2020

Adjuvant systemic treatment for carcinoma of the colon and rectum

1 reference

12 December 2020

1 reference

12 December 2020

MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity

1 reference

12 December 2020

Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer

1 reference

12 December 2020

Effect of levamisole on major histocompatibility complex class I expression in colorectal and breast carcinoma cell lines

1 reference

12 December 2020

Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01517209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7515770%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference